Related Experiment Video
Updated: May 20, 2026

Point-of-Care Kidney and Genitourinary Ultrasound in Adults: Image Acquisition
Published on: June 21, 2024
PET/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology
Katherine Zukotynski1, Aaron Lewis, Kevin O'Regan
1Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02115, USA. kzukotynski@partners.org
Objective:
PET/CT with (18)F-FDG shows metabolically active disease and is widely used for the diagnosis and follow-up of patients with cancer. Nonmetabolically active renal pathology may be missed without close attention to the CT portion of the study, whereas metabolically active pathology may be missed on PET because of physiologic tracer excretion in the kidneys. This article illustrates primary lesions of the kidney on FDG PET/CT with emphasis on key anatomic features and the appearance of tracer uptake.
Conclusion:
Close attention to both the FDG PET and CT portions of the study is essential to interpret renal pathology correctly on FDG PET/CT examinations.
Related Concept Videos
Imaging Studies II: Ultrasonography
Imaging Studies III: Computed Tomography
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Imaging Studies VII: Vascular Imaging

